Mitochondrial K(ATP) Channel Opening Protects a Human Atrial-derived Cell Line by a Mechanism Involving Free Radical Generation
Overview
Authors
Affiliations
Objectives: The mechanism by which the mitochondrial K(ATP) channel openers confer protection against ischemia/reperfusion injury is debated. Evidence suggests that rather than solely being an end effector, opening of these channels may act by a trigger mechanism. We examined the effects of the mitochondrial K(ATP) channel opener, diazoxide on parameters of mitochondrial function with specific reference to reactive oxygen species (ROS) generation in a human atrial derived cell line model of simulated ischemia/reperfusion (LSI/R).
Methods And Results: Propidium iodide (PI) exclusion was used to assess survival. Diazoxide treatment conferred protection against LSI/R (13.9+/-0.9% vs. 36.9+/-4.5% controls) that was abolished by pre-treatment with the mitoK(ATP) channel blocker, 5-hydroxydecanoate (5-HD) (33.3+/-3.6%) and with the free radical scavenger, 2-mercaptopropionylglycine (MPG) (29+/-4.0%). Diazoxide caused increased oxidation of the ROS probe, reduced mitotracker orange (1.3 vs. 1.0 arbitrary units for control; P<0.01 vs. control) that was abrogated by either 5-HD or MPG (1.07 and 1.07 arbitrary units, respectively). At the same time there was no change in orange fluorescent signal from the membrane potential sensitive probe, JC-1 indicating no change in mitochondrial membrane potential. Changes in light scattering, reflecting changes in mitochondrial volume, occurred during treatment with diazoxide.
Conclusion: These results demonstrate for the first time that the mitoK(ATP) channel opener diazoxide can act as a trigger of preconditioning by a mechanism involving mitochondrial swelling and the generation of ROS.
Naima J, Ohta Y Int J Mol Sci. 2024; 25(2).
PMID: 38279231 PMC: 10815940. DOI: 10.3390/ijms25021233.
Fellows C, Simone-Finstrom M, Anderson T, Swale D Virol J. 2023; 20(1):134.
PMID: 37349817 PMC: 10286336. DOI: 10.1186/s12985-023-02104-0.
The effect of an adaptation to hypoxia on cardiac tolerance to ischemia/reperfusion.
Naryzhnaya N, Maslov L, Derkachev I, Ma H, Zhang Y, Prasad N J Biomed Res. 2023; 37(4):230-254.
PMID: 37183617 PMC: 10387748. DOI: 10.7555/JBR.36.20220125.
Sharmin R, Nusantara A, Nie L, Wu K, Elias Llumbet A, Woudstra W ACS Sens. 2022; 7(11):3326-3334.
PMID: 36354956 PMC: 9706807. DOI: 10.1021/acssensors.2c01272.
Ahmad T, Wang J, Velez A, Suarez-Pierre A, Clement K, Dong J JTCVS Open. 2022; 8:338-354.
PMID: 36004142 PMC: 9390287. DOI: 10.1016/j.xjon.2021.07.036.